Milestone Scientific (NYSE:MLSS) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a report published on Wednesday. The firm issued a hold rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and issued a $1.25 price objective on shares of Milestone Scientific in a research note on Wednesday, November 20th.

Milestone Scientific Price Performance

Shares of NYSE:MLSS opened at $0.89 on Wednesday. Milestone Scientific has a 12 month low of $0.52 and a 12 month high of $1.10. The firm has a market capitalization of $68.93 million, a P/E ratio of -12.64 and a beta of 1.10. The company’s fifty day moving average price is $0.82 and its 200 day moving average price is $0.85.

Insider Transactions at Milestone Scientific

In related news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the completion of the transaction, the director now directly owns 4,606,882 shares in the company, valued at $4,284,400.26. The trade was a 2.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have sold 109,193 shares of company stock valued at $101,634 in the last quarter. 24.75% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Milestone Scientific

Institutional investors have recently modified their holdings of the company. World Investment Advisors LLC purchased a new position in shares of Milestone Scientific during the 3rd quarter worth about $91,000. Geode Capital Management LLC boosted its holdings in shares of Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new position in Milestone Scientific in the third quarter valued at $48,000. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.